High TRAF3IP3 expression in glioma tissues was associated with patients with neoplasm cancer tissue source site, and poorer overall survival (OS) (p = 0.03), which was validated using TCGA. This evidence concerns the gene TRAF3IP3 and central nervous system cancer.